General Information of the Compound
Compound ID |
CP0113519
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-(4-phenyl-1,3-thiazol-2-yl)-7-sulfanylheptanamide
Show/Hide
|
||||||||||||||||||
Synonyms |
7-mercapto-N-(4-phenyl-2-thiazolyl)heptanamide
7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide
BDBM19131
CHEMBL419758
JMC505425 Compound 7
N-(4-phenyl-1,3-thiazol-2-yl)-7-sulfanylheptanamide
NCH-31
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H20N2OS2
|
||||||||||||||||||
Molecular Weight |
320.483
|
||||||||||||||||||
Canonical SMILES |
SCCCCCCC(=O)Nc1nc(cs1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H20N2OS2/c19-15(10-6-1-2-7-11-20)18-16-17-14(12-21-16)13-8-4-3-5-9-13/h3-5,8-9,12,20H,1-2,6-7,10-11H2,(H,17,18,19)
Show/Hide
|
||||||||||||||||||
InChIKey |
LUXAHBUKMVESIS-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound